
BioPharm International Sponsored eBooks-10-21-2021
As bio/pharmaceutical companies navigate the capacity and supply chain challenges presented by the COVID-19 pandemic, attention also needs to be focused on emerging and established quality and regulatory challenges.
In this Regulatory Sourcebook, the editors share the latest insight and analysis for regulatory and industry trends, supply chain issues, and quality best practices including the following:
• Innovation and FDA’s Focus Areas of Regulatory Science report
• Serialization
• Counterfeit COVID-19 vaccines
• CMC strategies
• Data integrity
• Intellectual property

Advertisement
Advertisement
Trending on BioPharm International
1
Biocon’s Pebrilzo Becomes First Breast Cancer Treatment Biosimilar Approved Under EMA’s Tailored Clinical Approach
2
The BioPharm Brief: A Matrix-Targeting ADC in Head and Neck Cancer, an RNAi Approval in Myasthenia Gravis, and AbbVie Bets on AND-Gated Bispecifics
3
AbbVie and DISCO Partner on AND-Gated Bispecifics Designed to Recognize Tumor-Selective Protein Pairs
4
Evotec, BMS Gain Second FDA IND Acceptance for Molecular Glue Degrader
5
